Taro Pharmaceutical Industries Revenue 2006-2018 | TARO

Taro Pharmaceutical Industries revenue from 2006 to 2018. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
Taro Pharmaceutical Industries Annual Revenue
(Millions of US $)
2018 $662
2017 $879
2016 $951
2015 $863
2014 $759
2013 $671
2012 $145
2011 $0
2011 $108
2010 $0
2010 $89
2009 $85
2008 $313
2007 $184
2006 $0
2006 $298
2005 $79
Taro Pharmaceutical Industries Quarterly Revenue
(Millions of US $)
Q3 2018 $176
Q2 2018 $159
Q1 2018 $155
Q4 2018 $175
Q3 2017 $155
Q2 2017 $170
Q1 2017 $161
Q4 2017 $196
Q3 2016 $220
Q2 2016 $229
Q1 2016 $234
Q4 2016 $265
Q3 2015 $258
Q2 2015 $212
Q1 2015 $215
Q4 2015 $244
Q3 2014 $238
Q2 2014 $251
Q1 2014 $130
Q4 2014 $187
Q3 2013 $214
Q2 2013 $205
Q1 2013 $153
Q4 2013 $165
Q3 2012 $186
Q2 2012 $161
Q1 2012 $159
Q4 2012 $145
Q3 2011 $148
Q2 2011 $138
Q1 2011 $112
Q4 2011 $108
Q3 2010 $102
Q2 2010 $103
Q1 2010 $98
Q4 2010 $89
Q3 2009 $85
Q2 2009 $94
Q1 2009 $97
Q4 2009 $0
Q3 2008 $85
Q2 2008 $90
Q3 2007 $0
Q3 2006 $0
Q4 2006 $79
Q3 2005 $68
Q2 2005 $73
Q1 2005 $79
Q4 2005 $79
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $4.247B $0.662B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $46.886B 31.19
Takeda Pharmaceutical (TAK) Japan $32.716B 12.10
Grifols (GRFS) Spain $12.878B 15.61
Ionis Pharmaceuticals (IONS) United States $10.920B 33.86
Jazz Pharmaceuticals (JAZZ) Ireland $7.794B 11.16
Neurocrine Biosciences (NBIX) United States $7.730B 500.65
Sage Therapeutics (SAGE) United States $7.380B 0.00
Tilray (TLRY) United States $6.257B 0.00
Catalent (CTLT) United States $5.923B 24.80
Nektar Therapeutics (NKTR) United States $5.601B 8.94
United Therapeutics (UTHR) United States $5.282B 8.98
FibroGen (FGEN) United States $4.533B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.197B 22.30
Zogenix (ZGNX) United States $2.223B 0.00
PTC Therapeutics (PTCT) United States $2.194B 0.00
Portola Pharmaceuticals (PTLA) United States $2.136B 0.00
Aerie Pharmaceuticals (AERI) United States $2.128B 0.00
Ironwood Pharmaceuticals (IRWD) United States $2.106B 0.00
Madrigal Pharmaceuticals (MDGL) United States $2.070B 0.00
USANA Health Sciences (USNA) United States $2.010B 16.87
Endo (ENDP) Ireland $1.869B 2.88
Heron Therapeutics (HRTX) United States $1.859B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.855B 23.10
Xencor (XNCR) United States $1.685B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.674B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.576B 136.50
Corcept Therapeutics (CORT) United States $1.281B 18.62
Theravance Biopharma (TBPH) Cayman Islands $1.280B 0.00
TherapeuticsMD (TXMD) United States $1.252B 0.00
Esperion Therapeutics (ESPR) United States $1.110B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.063B 0.00
Tricida (TCDA) United States $1.009B 0.00
Radius Health (RDUS) United States $0.866B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.813B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.591B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.569B 0.00
Odonate Therapeutics (ODT) United States $0.560B 0.00
GlycoMimetics (GLYC) United States $0.560B 0.00
ChemoCentryx (CCXI) United States $0.551B 0.00
Dermira (DERM) United States $0.550B 0.00
Collegium Pharmaceutical (COLL) United States $0.527B 0.00
ArQule (ARQL) United States $0.525B 0.00
Forty Seven (FTSV) United States $0.508B 0.00
KalVista Pharmaceuticals (KALV) United States $0.486B 0.00
Akebia Therapeutics (AKBA) United States $0.479B 0.00
Flexion Therapeutics (FLXN) United States $0.475B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.473B 27.90
Siga Technologies (SIGA) United States $0.466B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.413B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.410B 0.00
TCR2 THERAPTCS (TCRR) United States $0.407B 0.00
Translate Bio (TBIO) United States $0.404B 0.00
Aptorum Group (APM) China $0.381B 0.00
OptiNose (OPTN) United States $0.379B 0.00
Concert Pharmaceuticals (CNCE) United States $0.365B 0.00
ImmunoGen (IMGN) United States $0.360B 0.00
Karyopharm Therapeutics (KPTI) United States $0.331B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.313B 11.60
Verrica Pharmaceuticals (VRCA) United States $0.297B 0.00
CASI Pharmaceuticals (CASI) United States $0.296B 0.00
Minerva Neurosciences (NERV) United States $0.296B 0.00
Immune Design (IMDZ) United States $0.283B 0.00
Lannett Co Inc (LCI) United States $0.281B 2.61
Mast Therapeutics (SVRA) United States $0.278B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.272B 0.00
Xeris Pharmaceuticals (XERS) United States $0.268B 0.00
Majesco Entertainment (PTE) United States $0.266B 0.00
Aclaris Therapeutics (ACRS) United States $0.253B 0.00
Affimed (AFMD) Germany $0.250B 0.00
Calithera Biosciences (CALA) United States $0.249B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.249B 0.00
HARPOON THERAPT (HARP) United States $0.249B 0.00
Dova Pharmaceuticals (DOVA) United States $0.248B 0.00
ElectroCore (ECOR) United States $0.239B 0.00
Opexa Therapeutics (ACER) United States $0.231B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
Recro Pharma (REPH) United States $0.213B 0.00
Tyme Technologies (TYME) United States $0.213B 0.00
Ardelyx (ARDX) United States $0.210B 0.00
Galectin Therapeutics (GALT) United States $0.208B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.206B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.202B 0.00
Molecular Templates (MTEM) United States $0.199B 0.00
Jounce Therapeutics (JNCE) United States $0.198B 0.00
Aldeyra Therapeutics (ALDX) United States $0.196B 0.00
Rafael Holdings (RFL) United States $0.193B 0.00
Redhill Biopharma (RDHL) Israel $0.186B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.183B 0.00
IMV INC (IMV) Canada $0.182B 0.00
Aratana Therapeutics (PETX) United States $0.180B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.179B 0.00
Nature's Sunshine Products (NATR) United States $0.176B 182.20
Ocular Therapeutix (OCUL) United States $0.169B 0.00
Neos Therapeutics (NEOS) United States $0.163B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.162B 0.00
Aquestive Therapeutics (AQST) United States $0.155B 0.00
Neon Therapeutics (NTGN) United States $0.151B 0.00
AgeX Therapeutics (AGE) United States $0.147B 0.00
MediWound (MDWD) Israel $0.140B 0.00
ProNAi Therapeutics (SRRA) Canada $0.139B 0.00
China SXT Pharmaceuticals (SXTC) China $0.138B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.127B 0.00
Cardiome Pharma (CORV) Canada $0.123B 0.00
Champions Oncology (CSBR) United States $0.117B 0.00
DURECT (DRRX) United States $0.113B 0.00
Zafgen (ZFGN) United States $0.106B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.106B 0.00
Adherex Technologies (FENC) United States $0.104B 0.00
Iterum Therapeutics (ITRM) Ireland $0.101B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.100B 0.00
Infinity Pharmaceuticals (INFI) United States $0.100B 0.00
Nivalis Therapeutics (ALPN) United States $0.095B 0.00
Avenue Therapeutics (ATXI) United States $0.089B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.088B 0.00
India Globalization Capital (IGC) United States $0.087B 0.00
Otonomy (OTIC) United States $0.084B 0.00
Natural Alternatives (NAII) United States $0.082B 8.06
SCYNEXIS (SCYX) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.075B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.066B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.066B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.063B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.060B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
CTI BioPharma (CTIC) United States $0.056B 0.00
Bio-Path Holdings (BPTH) United States $0.055B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.055B 0.00
KemPharm (KMPH) United States $0.053B 0.00
Lipocine (LPCN) United States $0.053B 0.00
Capnia (SLNO) United States $0.052B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.050B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.050B 0.00
BioLineRx (BLRX) Israel $0.048B 0.00
Melinta Therapeutics (MLNT) United States $0.046B 0.00
Mannatechorporated (MTEX) United States $0.043B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.040B 0.00
NOVAN INC (NOVN) United States $0.039B 0.00
ProPhase Labs (PRPH) United States $0.037B 0.00
ContraFect (CFRX) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.034B 0.00
Achaogen (AKAO) United States $0.033B 0.00
Heat Biologics (HTBX) United States $0.029B 0.00
PharmAthene (ALT) United States $0.026B 0.00
IsoRay (ISR) United States $0.026B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.025B 0.00
Shineco (TYHT) China $0.025B 4.23
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
Onconova Therapeutics (ONTX) United States $0.024B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.024B 0.00
Citius Pharmaceuticals (CTXR) United States $0.024B 0.00
Biomerica (BMRA) United States $0.023B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.022B 0.00
ESSA Pharma (EPIX) Canada $0.022B 0.00
Jaguar Animal Health (JAGX) United States $0.022B 0.00
NanoViricides (NNVC) United States $0.021B 0.00
Pain Therapeutics (PTIE) United States $0.021B 0.00
Cyanotech (CYAN) United States $0.019B 0.00
Achieve Life Sciences (ACHV) United States $0.019B 0.00
Xenetic Biosciences (XBIO) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.018B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.017B 0.00
VAXART, INC (VXRT) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Regulus Therapeutics (RGLS) United States $0.011B 0.00
Midatech Pharma (MTP) United Kingdom $0.010B 0.00
Trillium Therapeutics (TRIL) Canada $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.008B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.006B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.006B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Bio Blast Pharma (ORPN) Israel $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00